These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38537063)

  • 21. Clinical outcomes of hundred large Impella implantations in cardiogenic shock patients based on individual clinical scenarios.
    Sugimura Y; Bauer S; Immohr MB; Mehdiani A; Rellecke P; Tudorache I; Horn P; Westenfeld R; Boeken U; Aubin H; Lichtenberg A; Akhyari P
    Artif Organs; 2023 Dec; 47(12):1874-1884. PubMed ID: 37724611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-Term Outcomes of Impella Support in Japanese Patients With Cardiogenic Shock Due to Acute Myocardial Infarction　- Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD).
    Ikeda Y; Ako J; Toda K; Hirayama A; Kinugawa K; Kobayashi Y; Ono M; Nishimura T; Sato N; Shindo T; Takayama M; Yasukochi S; Shiose A; Sawa Y;
    Circ J; 2023 Apr; 87(5):588-597. PubMed ID: 36682787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
    Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
    Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ECMO and Impella Support Strategies as a Bridge to Surgical Repair of Post-Infarction Ventricular Septal Rupture.
    Coyan G; Anand N; Imran M; Gomez H; Ramanan R; Murray H; Sanon S; Yoon P; Kaczorowski D; Bonatti J
    Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35630028
    [No Abstract]   [Full Text] [Related]  

  • 25. Impella 5.0 as a Second-Line Mechanical Circulatory Support Strategy After Extracorporeal Life Support.
    Schibilsky D; Kruger T; Lausberg HF; Eisenlohr C; Haller C; Nemeth A; Schibilsky B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2016 Sep; 40(9):909-16. PubMed ID: 27645397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulatory Support with Extracorporeal Membrane Oxygenation and/or Impella for Cardiogenic Shock During Myocardial Infarction.
    Mourad M; Gaudard P; De La Arena P; Eliet J; Zeroual N; Rouvière P; Roubille F; Albat B; Colson PH
    ASAIO J; 2018; 64(6):708-714. PubMed ID: 29240628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.
    Garan AR; Eckhardt C; Takeda K; Topkara VK; Clerkin K; Fried J; Masoumi A; Demmer RT; Trinh P; Yuzefpolskaya M; Naka Y; Burkhoff D; Kirtane A; Colombo PC; Takayama H
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):755-765. PubMed ID: 29094607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Impella 5.0 and extracorporeal left ventricular assist device in patients with cardiogenic shock.
    Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Okumura T; Shibata N; Kazama S; Kimira Y; Oishi H; Kuwayama T; Hiraiwa H; Usui A; Murohara T
    Int J Artif Organs; 2021 Nov; 44(11):846-853. PubMed ID: 34488481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    Saito S; Okubo S; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Takei Y; Tezuka M; Tsuchiya G; Konishi T; Shibasaki I; Ogata K; Fukuda H
    J Cardiol; 2024 Apr; 83(4):228-235. PubMed ID: 37926367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impella 5.0 supported oncological surgery as bridge to LVAD.
    Montisci A; Micheletto G; Sibilio S; Donatelli F; Tespili M; Banfi C; Casilli F; Cosseta D; Miceli A; Cirri S; Pappalardo F
    ESC Heart Fail; 2021 Feb; 8(1):167-170. PubMed ID: 33161652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.
    Takeda K; Garan AR; Topkara VK; Kirtane AJ; Karmpaliotis D; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takayama H
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):591-596. PubMed ID: 27818380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre.
    Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y
    Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Budget Impact Analysis of Impella CP
    Delmas C; Pernot M; Le Guyader A; Joret R; Roze S; Lebreton G
    Adv Ther; 2022 Mar; 39(3):1293-1309. PubMed ID: 35067868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended Support With the Impella 5.5: Transplant, ECMO, and Complications.
    Cohen WG; Rekhtman D; Iyengar A; Shin M; Ibrahim M; Bermudez C; Cevasco M; Wald J
    ASAIO J; 2023 Jul; 69(7):642-648. PubMed ID: 37039780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impella CP use in patients with non-ischaemic cardiogenic shock.
    Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock.
    Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F
    J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the Impella 5.0 with a right axillary artery approach as bridge to long-term mechanical circulatory assistance.
    Pozzi M; Quessard A; Nguyen A; Mastroianni C; Niculescu M; Pavie A; Leprince P
    Int J Artif Organs; 2013 Oct; 36(9):605-11. PubMed ID: 23918265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of patients with non-ischaemic cardiogenic shock supported by percutaneous left ventricular assist device.
    Haurand JM; Haberkorn S; Haschemi J; Oehler D; Aubin H; Akhyari P; Boeken U; Kelm M; Westenfeld R; Horn P
    ESC Heart Fail; 2021 Oct; 8(5):3594-3602. PubMed ID: 34424614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.